Search

Author/Creator Vonghia, L.

1. Screening for therapeutic trials and treatment indication in clinical practice: MACK‐3, a new blood test for the diagnosis of fibrotic NASH. Issue 10 (25th March 2018)

Authors:
Boursier, J.; Anty, R.; Vonghia, L.; Moal, V.; Vanwolleghem, T.; Canivet, C. M.; Michalak, S.; Bonnafous, S.; Michielsen, P.; Oberti, F.; Iannelli, A.; Van Gaal, L.; Patouraux, S.; Blanchet, O.; Verrijken, A.; Gual, P.; Rousselet, M.‐C.; Driessen, A.; Hunault, G.; Bertrais, S.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 47:Issue 10(2018)
Page Start:
1387
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. The U2-spliceosome and its interactors regulate the levels and activity of the LDL receptor in humans. (December 2020)

Authors:
Zanoni, P.; Panteloglou, G.; Othman, A.; Haas, J.T.; Meier, R.; Rimbert, A.; Futema, M.; Khalil, Y. Abou; Norrelykke, S.F.; Rzepiela, A.J.; Stoma, S.; Stebler, M.; Van Dijk, F.; Wijers, M.; Wolters, J.C.; Dalila, N.; Huijkman, N.; Smit, M.; Gallo, A.; Carreau, V.
Journal:
Atherosclerosis
Issue:
Volume 315(2020)
Page Start:
e15
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search